Cargando…

An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care

OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epileps...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Steenkiste, Frank, Fidèle, Sebera, Nsanzabaganwa, Wellars, Uwacu, Beni, Dedeken, Peter, Teuwen, Dirk E., Boon, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398151/
https://www.ncbi.nlm.nih.gov/pubmed/30868122
http://dx.doi.org/10.1002/epi4.12304
_version_ 1783399532801818624
author Van Steenkiste, Frank
Fidèle, Sebera
Nsanzabaganwa, Wellars
Uwacu, Beni
Dedeken, Peter
Teuwen, Dirk E.
Boon, Paul
author_facet Van Steenkiste, Frank
Fidèle, Sebera
Nsanzabaganwa, Wellars
Uwacu, Beni
Dedeken, Peter
Teuwen, Dirk E.
Boon, Paul
author_sort Van Steenkiste, Frank
collection PubMed
description OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epilepsy center in Rwanda. METHODS: In June 2016 (T1), as a first stage of this single‐center cohort study, an ambispective chart review was conducted on baseline sociodemographic and disease characteristics of PwE using a structured questionnaire. Missing data were obtained by phone interview. In 2017, follow‐up data were collected by phone interview on treatment outcomes after 15‐months (T2). RESULTS: Of 406 PwE screened, 235 were included at T1 and outcomes on 166 PwE were obtained at T2. More than 70% were <20 years of age, with a male preponderance. A high number of patients were aged ≥20 years, were single (67.4%), unemployed (41.5%), and had no formal education or primary level education (53.9%), possibly reflecting stigma. A mean delay in diagnosis since first seizure increased with age at first seizure, amounting to 3 years for patients aged ≥20 years. At T2, 69.6% of 166 patients who could be contacted reported no seizures in the previous month. Valproate monotherapy was the most frequently prescribed treatment. At T2, 47% had discontinued treatment, which was often not recommended by a physician, despite medical insurance coverage in >90% of patients. Only 19% reported an adverse event. Marked and partial improvement in quality of life (QoL) was reported by, respectively, 50.9% and 32.7% of patients. SIGNIFICANCE: Encouraging results on improved seizure control and QoL were observed at follow‐up. The treatment gap remains high due to loss to follow‐up and treatment discontinuation. In this article, we discuss needs and recommendations for improving patient care, requiring concerted efforts of stakeholders at all levels of the healthcare system.
format Online
Article
Text
id pubmed-6398151
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63981512019-03-13 An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care Van Steenkiste, Frank Fidèle, Sebera Nsanzabaganwa, Wellars Uwacu, Beni Dedeken, Peter Teuwen, Dirk E. Boon, Paul Epilepsia Open Full‐length Original Research OBJECTIVE: Because outcome data inform and drive healthcare decisions and improvement of patient care, this study aimed to gain a deep understanding of sociodemographic profiles and treatment outcomes of newly presenting and recently diagnosed persons living with epilepsy (PwE) at a tertiary epilepsy center in Rwanda. METHODS: In June 2016 (T1), as a first stage of this single‐center cohort study, an ambispective chart review was conducted on baseline sociodemographic and disease characteristics of PwE using a structured questionnaire. Missing data were obtained by phone interview. In 2017, follow‐up data were collected by phone interview on treatment outcomes after 15‐months (T2). RESULTS: Of 406 PwE screened, 235 were included at T1 and outcomes on 166 PwE were obtained at T2. More than 70% were <20 years of age, with a male preponderance. A high number of patients were aged ≥20 years, were single (67.4%), unemployed (41.5%), and had no formal education or primary level education (53.9%), possibly reflecting stigma. A mean delay in diagnosis since first seizure increased with age at first seizure, amounting to 3 years for patients aged ≥20 years. At T2, 69.6% of 166 patients who could be contacted reported no seizures in the previous month. Valproate monotherapy was the most frequently prescribed treatment. At T2, 47% had discontinued treatment, which was often not recommended by a physician, despite medical insurance coverage in >90% of patients. Only 19% reported an adverse event. Marked and partial improvement in quality of life (QoL) was reported by, respectively, 50.9% and 32.7% of patients. SIGNIFICANCE: Encouraging results on improved seizure control and QoL were observed at follow‐up. The treatment gap remains high due to loss to follow‐up and treatment discontinuation. In this article, we discuss needs and recommendations for improving patient care, requiring concerted efforts of stakeholders at all levels of the healthcare system. John Wiley and Sons Inc. 2019-02-21 /pmc/articles/PMC6398151/ /pubmed/30868122 http://dx.doi.org/10.1002/epi4.12304 Text en © 2019 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Full‐length Original Research
Van Steenkiste, Frank
Fidèle, Sebera
Nsanzabaganwa, Wellars
Uwacu, Beni
Dedeken, Peter
Teuwen, Dirk E.
Boon, Paul
An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title_full An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title_fullStr An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title_full_unstemmed An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title_short An ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in Rwanda and recommendations for improved epilepsy care
title_sort ambispective cohort study on treatment outcomes of patients with epilepsy in a tertiary epilepsy center in rwanda and recommendations for improved epilepsy care
topic Full‐length Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398151/
https://www.ncbi.nlm.nih.gov/pubmed/30868122
http://dx.doi.org/10.1002/epi4.12304
work_keys_str_mv AT vansteenkistefrank anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT fidelesebera anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT nsanzabaganwawellars anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT uwacubeni anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT dedekenpeter anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT teuwendirke anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT boonpaul anambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT vansteenkistefrank ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT fidelesebera ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT nsanzabaganwawellars ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT uwacubeni ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT dedekenpeter ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT teuwendirke ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare
AT boonpaul ambispectivecohortstudyontreatmentoutcomesofpatientswithepilepsyinatertiaryepilepsycenterinrwandaandrecommendationsforimprovedepilepsycare